Literature DB >> 21834851

Recent issues in contrast-induced nephropathy.

Kazuhiro Kitajima1, Tetsuo Maeda, Sanae Watanabe, Kazuro Sugimura.   

Abstract

Contrast-induced nephropathy (CIN) is a serious complication resulting from the use of iodinated contrast medium (CM) with potentially high morbidity and mortality. Patients with pre-existing renal insufficiency appear to be at higher risk of CIN. To prevent CIN among patients undergoing contrast-enhanced computed tomography, every effort is required, including routine identification of at-risk patients, the use of appropriate hydration regimens, withdrawal of nephrotoxic drugs, selection of low-osmolality CM or iso-osmolar CM, and using the minimum volume of CM possible.
© 2011 The Japanese Urological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21834851     DOI: 10.1111/j.1442-2042.2011.02830.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  5 in total

1.  Diagnostic accuracy of contrast-enhanced ultrasound in assessing the therapeutic response to radio frequency ablation for liver tumors: systematic review and meta-analysis.

Authors:  Min Xuan; Fengsheng Zhou; Yan Ding; Qiaoying Zhu; Ji Dong; Hao Zhou; Jun Cheng; Xiao Jiang; Pengxi Wu
Journal:  Surg Endosc       Date:  2017-12-21       Impact factor: 4.584

2.  Efficacy of oral supplemental hydration for the prevention of contrast-induced nephropathy in rats.

Authors:  Tamaki Matsunami; Kazuo Hino; Rie Dosho; Sho Miyatake; Goro Ebisu; Ryohei Kuwatsuru
Journal:  Jpn J Radiol       Date:  2017-02-15       Impact factor: 2.374

3.  Safety and Efficacy of Tolvaptan for the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Heart Failure and Chronic Kidney Disease.

Authors:  Kennosuke Yamashita; Wataru Igawa; Morio Ono; Takehiko Kido; Toshitaka Okabe; Myong Hwa Yamamoto; Kisaki Amemiya; Naoei Isomura; Hiroshi Araki; Masahiko Ochiai
Journal:  Kidney Dis (Basel)       Date:  2018-11-29

4.  Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.

Authors:  Guoqiang Gu; Xuechao Yuan; Yaqing Zhou; Demin Liu; Wei Cui
Journal:  BMC Cardiovasc Disord       Date:  2019-06-24       Impact factor: 2.298

5.  Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy - a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial.

Authors:  Barbara Biernacka-Fiałkowska; Marta Szuksztul; Wojciech Suślik; Karolina Dzierwa; Łukasz Tekieli; Magdalena Kostkiewicz; Piotr Podolec; Piotr Pieniążek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-03-22       Impact factor: 1.426

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.